COMMUNIQUÉS West-GlobeNewswire

Block Listing Update

30/11/2017 - 18:41

LONDON, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Title21 Health Solutions® to Showcase its BMT Software Solution 8.5 at the 2018 BMT Tandem Meeting

30/11/2017 - 18:00

PLEASANTON, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Title21 Health Solutions, “Title21”, an innovator of integrated enterprise software for blood and marrow transplant programs supporting high-quality and world-class [...]

VALNEVA Expands its Commercial Operations and Establishes US Infrastructure

30/11/2017 - 17:51

Valneva Expands its Commercial Operations and Establishes US Infrastructure Lyon (France), November 30, 2017 - Valneva SE, a fully integrated commercial stage biotech company focused on developing innovative, lifesaving [...]

VALNEVA poursuit le développement de ses activités commerciales avec la mise en place d'une infrastructure aux Etats-Unis

30/11/2017 - 17:51

Valneva poursuit le développement de ses activités commerciales avec la mise en place d'une infrastructure aux Etats-Unis Lyon (France), 30 novembre 2017 - Valneva SE, ("Valneva" ou "le Groupe"), société de [...]

Hemostemix Drives Forward with Talented New Management into New Headquarters

30/11/2017 - 17:17

NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) is pleased [...]

Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical

30/11/2017 - 16:45

TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (NASDAQ: IPCI ) and (TSX: IPCI ) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, [...]

Avivagen Announces Closing of Private Placement Totaling $4 million

30/11/2017 - 16:36

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Nov. 30, 2017 (GLOBE NEWSWIRE) -- [...]

Sales of Olainfarm in Nine Months Reach 90.4 Million Euros

30/11/2017 - 16:17

Olaine, 2017-11-30 16:17 CET (GLOBE NEWSWIRE) -- AS Olainfarm just had its best third quarter in terms of sales, as company’s sales reached 27.7 million euros, representing an increase by 10%. During this quarter, the [...]

BeyondSpring Initiates Global Phase 2/3 Trial with Plinabulin in China for the Prevention of Chemotherapy-Induced Neutropenia to Demonstrate Superiority

30/11/2017 - 15:58

NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced [...]

BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study

30/11/2017 - 15:27

MALVERN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and [...]

TearLab Launches Registered Direct Offering

30/11/2017 - 15:15

SAN DIEGO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”), today announced that it is launching a registered direct offering to raise gross proceeds of [...]

Symphony Health Launches New Long Term Care Channel Offering

30/11/2017 - 15:00

CONSHOHOCKEN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Symphony Health , a PRA Health Sciences company and a leading provider of data, cloud-based analytics and consulting solutions to life science companies and [...]

Scythian Biosciences Corp. Completes Sale of Go Green

30/11/2017 - 15:00

TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC Pink:SCCYF) is pleased to announce that it has entered into a share purchase [...]

TOMI Environmental Solutions, Inc. Joins Forces With Protak Scientific in Ground Breaking Partnership

30/11/2017 - 15:00

BEVERLY HILLS, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]

RespireRx Pharmaceuticals Inc. Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea

30/11/2017 - 14:45

Glen Rock, N.J, Nov. 30, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”) announces that the results of the PACE (Pharmacotherapy of Apnea by Cannabimimetic [...]

PDMR Dealing

30/11/2017 - 14:42

LONDON, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing

30/11/2017 - 14:41

BETHLEHEM, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced several new HIV testing-related [...]

Industry Veteran Dr. Meqsood Rehman Promoted to Chief Executive Officer of Gala Global Inc.

30/11/2017 - 14:36

ORANGE COUNTY, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Gala Global, Inc. (OTCBB: GLAG ) today announced that it has promoted Dr. Meqsood Rehman, 41, to the Chief Executive Officer of Gala Global, Inc., taking over [...]

SeaSpine Announces FDA 510(k) Clearance of OsteoBallast™ Demineralized Bone Matrix in Resorbable Mesh

30/11/2017 - 14:30

CARLSBAD, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]